301103.SZ
何氏眼科
SZSE · Q 卫生 · CN
CNY 16.39
−2.09%Year over year
Reported trailing growth
- Revenue
- +0.4%
- EBITDA
- —
- EBIT
- +450.4%
- EPS
- +214.8%
- Free cash flow
- +46.6%
- Operating cash flow
- -13.6%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +4.6%
- EBITDA
- -0.6%
- EBIT
- -6.5%
- Net income
- -5.7%
- EPS
- -7.7%
- Free cash flow
- +7.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026